Stereotactic ablative radiotherapy for oligometastatic cancers: Efficacy and toxicity results from the randomized SABR-COMET Trial

S. Senan, R. Olson, S. Harrow, S. Gaede, A. Louie, C. Haasbeek, L. Mulroy, M. Lock, G. Rodrigues, B. Yaremko, D. Schellenberg, B. Ahmad, G. Griffioen, S. Senthi, M. Liu, K. Moore, S. Currie, G. Bauman, A. Warner, D. Palma

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Original languageEnglish
Pages (from-to)ix170
Number of pages1
JournalAnnals of Oncology
Issue numberSupplement 9
Publication statusPublished - 1 Nov 2018
Externally publishedYes

Cite this